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Abstract 
Coeliac disease (CD) is an autoimmune disorder which leads to chronic inflammation of 
the gut. Furthermore, CD is associated with upper gastrointestinal malignancies, 
particularly lymphoma of the small intestine. Besides lymphoma, an increased frequency 
of associated small bowel carcinoma has been described. Here we report the case of a 
70-year-old male suffering from CD who was treated with a gluten-free diet presenting 
with complaints of nausea, vomiting and weight loss of about 8 kg in two months. He 
underwent esophagogastroduodenoscopy, which identified distention of the stomach 
and duodenum and in the pars horizontalis a distinct obstruction was suggestive. 
However, histopathological examination showed a normal mucosal membrane. 
Additionally, a computed tomography scan of the abdomen was performed which 
showed an expanded stomach and duodenum up to the ligament of Treitz. During an 
explorative laparotomy a small tumor was palpated near the ligament of Treitz. 
Subsequently, a duodenal segment resection was performed. After surgery, the patient 
recovered well and left our hospital in good condition. 
Background 
Coeliac disease (CD), also called gluten-sensitive enteropathy or nontropical sprue, is a 
unique autoimmune disorder which results from the interaction between gluten and 
immune, genetic and environmental factors [1]. Originally CD was considered as a 
malabsorption syndrome of childhood, whereas it is now recognized as a disease which 
may be diagnosed at any age. Clinical manifestations of CD differ greatly among patients,  
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varying from vague symptoms such as fatigue or malaise to a classical malabsorption 
syndrome including diarrhoea and steatorrhoea accompanied by abdominal pain or 
discomfort [2]. The cornerstone of the treatment of CD is a lifelong gluten-free diet 
(GFD) which leads to noticeable clinical improvement within two weeks in about 70% of 
patients [3]. 
Several studies have suggested increased mortality from gastrointestinal malignancies 
in patients with CD compared to the general population [1, 4–6]. Particularly the risk of 
small bowel malignancies, which is generally an uncommon form of cancer, is increased. 
We report a case of duodenal carcinoma in a patient suffering for CD. 
Case Report 
In September 2008, a 70-year-old Caucasian male was referred by his general practitioner due to 
malaise, nausea, vomiting and weight loss of about 8 kg in two months. In his medical history, the 
patient had undergone a Hartmann procedure in 1998 because of a perforated diverticulitis. In 1999 a 
reversal of the Hartmann procedure had occurred. In 2001 the patient had been diagnosed with CD by 
an esophagogastroduodenoscopy with duodenal biopsies for which he was treated with a GFD on which 
he responded well clinically and which he followed meticulously. 
At admission, we performed an esophagogastroduodenoscopy which showed distention of the 
stomach and duodenum with retention of gastric and enteric fluid; more than 500 ml was aspirated. 
There was no problem in passing the pylorus. At the point of maximal intubation in the pars 
horizontalis, a distinct obstruction was suggestive with kinking and fixation but without evident 
pathology of the mucosa. Biopsies were taken but probably not at the point of maximum obstruction, 
which could not be reached because of kinking. Histology showed a normal mucosal membrane of the 
duodenum, without villous atrophy or increased intraepithelial lymphocytes. Additionally, a computed 
tomography scan of the abdomen was performed which showed an expanded stomach and duodenum 
up to the ligament of Treitz. An explorative laparotomy was performed, during which a small tumor 
was palpated near the ligament of Treitz. Subsequently, a duodenal segment resection was performed. 
Histological analyses revealed a moderately differentiated, infiltrating adenocarcinoma of 1.5 cm 
penetrating the muscularis propria and serosa, without invasion of local lymph nodes (stage T3N0M0 
AJCC VI ed 2002) (fig. 1, fig. 2). After surgery, patient recovered well and left our hospital in good 
condition. 
Discussion 
Malignancies involving the small bowel occur very infrequently in the general 
population. In the Netherlands, less than 100 cases a year of small bowel malignancies are 
revealed while at least 10,000 colorectal carcinomas are diagnosed. Despite the fact that 
the small bowel represents about 75% of the length and 90% of the surface area of the 
gastrointestinal tract, small bowel malignancies comprise about 2% of all gastrointestinal 
malignancies [7]. Next to the rarity of these lesions, the signs and symptoms patients 
present are usually vague and poorly defined, often delaying a correct diagnosis. 
Furthermore, conventional radiographic studies of the upper and lower intestinal tract 
often appear normal [8]. 
The association between carcinoma of the small bowel and CD was first reported in 
1958 [9]. Since then, the association between CD and small bowel carcinoma is persistent 
although only based on a small number of patients of which the greater part is in the form 
of case reports. Swinson et al. [10] indicated that CD patients have an increased risk of 
developing small bowel adenocarcinoma (relative risk 82.6-fold). In addition, results of a  
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national survey in the United States revealed similar results (relative risk 67-fold) [11]. A 
large population-based study of malignancy in patients which CD performed in Sweden 
confirmed the increased risk for small bowel cancer, although the risk was less compared 
to previous studies (10-fold) [12].  
The etiologic factors predisposing to malignancy in CD are uncertain. Possibilities 
include immunologic disturbance associated with mucosal lymphocyte infiltration, 
premalignant changes in the damaged surface epithelial cells, increased permeability 
to oncogenic factors and malabsorption of protective substances such as vitamins A 
and E [10, 11]. Another hypothesis which has been postulated is that small bowel 
adenocarcinoma in CD arises through an adenoma-carcinoma sequence [13]. However, 
currently there are conflicting results regarding this hypothesis [14–17]. 
Despite the fact that a lifelong GFD leads to noticeable clinical and histological 
improvement in about 70% of patients [3], studies about the protective effect of GFD on 
malignancy are scarce. Most studies suggest that a GFD leads to a decreased incidence of 
lymphoma, cancer of the mouth, pharynx and oesophagus and a decreased mortality in 
CD [18–21]. However, according to our knowledge only one case report was published 
about the specific role of GFD concerning small bowel malignancy [22]. This report did 
not show a protective effect of GFD, however, further research is needed to confirm this 
hypothesis.  
In conclusion, the present patient is an illustration that CD is a serious disease with 
possible serious complications such as duodenal adenocarcinoma. Despite the association 
between CD and small bowel malignancy, currently there are no recommendations for 
screening for this type of malignancy nor specific protocols for the follow-up of patients 
with CD. In view of our finding and based on the present scientific literature, we 
recommend that clinicians should take into account the possibility of small bowel 
malignancy in CD patients with vague symptoms such as fatigue or malaise, especially in 
combination with weight loss, despite a well-maintained GFD. In these patients early 
upper gastrointestinal endoscopy with duodenal biopsy should be performed. 
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Fig. 1. Duodenal segment resection showing the stenotic section. 
 
 
 
Fig. 2. Histology of the stenotic segment of the duodenum revealing a moderately differentiated 
infiltrative adenocarcinoma penetrating the muscularis propria and serosa. 
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